External Controls In Clinical Research, Part 2: Informed Choices Amidst a Portfolio of Options

Informed choices amidst a portfolio of options

December 16, 2020
Michael Murphy, MD, PhD | Missy Vadnais | Andrew Kuhlman

This white paper explores the pros and cons of utilizing the nontraditional approach of an external control in your clinical trial.

Your form has been successfully submitted! Click the button below to access.
VIEW PDF
Michael Murphy, MD, PhD
MEET THE AUTHOR

Michael Murphy, MD, PhD

Chief Medical and Scientific Officer
LEARN MORE